Ground Truths

Ground Truths is a Substack focused on the intersection of biomedicine and technology, providing in-depth analysis on COVID-19, autoimmune diseases, vaccine development, genetic research, the integration of AI in healthcare, and the future implications of biotechnological advances.

COVID-19 Research and Vaccines Autoimmune Diseases and Treatments Genetic Research and Lifespan Extension Artificial Intelligence in Healthcare Biotechnological Advances Cardiovascular Health Diagnostic Errors in Medicine

The hottest Substack posts of Ground Truths

And their main takeaways
15003 implied HN points 13 Mar 24
  1. The global excess mortality due to Covid has reached about 30 million lost lives, impacting life expectancy in 204 countries. Long Covid continues to affect tens of millions worldwide.
  2. Vaccination rates and political affiliation have shown stark differences in Covid death rates, with data indicating the protective benefits of boosters for older individuals.
  3. New variants of SARS-CoV-2, like BA.2.87.1, are being monitored for mutations, with the current consensus suggesting it is less immune-evasive. Vaccines have shown major protection against cardiovascular outcomes.
10104 implied HN points 28 Feb 24
  1. Two new studies show cognitive deficits after Covid in large populations, with impacts on memory, executive function, and reasoning.
  2. The cognitive decline from Long Covid can range from 3 to 9 IQ points, showing significant impact even after symptoms resolve.
  3. Research indicates that cognitive decline from Covid can persist for up to 3 years, emphasizing the long-term effects of the virus on brain function.
10191 implied HN points 22 Feb 24
  1. Recent studies shed light on the disrupted blood-brain barrier in Long Covid, with implications for brain fog and inflammation.
  2. Persistent SARS-CoV-2 infections increase the risk of Long Covid, with viral loads indicating active replication.
  3. Interferon-gamma biomarker shows promise in diagnosing and treating Long Covid, potentially aiding in clinical trials.
15222 implied HN points 19 Jan 24
  1. A new study on Long Covid analyzed 6,600 proteins to identify potential biomarkers like complement activation.
  2. Vaccination offers substantial protection against Long Covid, especially in those not at risk of severe illness.
  3. Recent reports highlight potential neurologic damage from Covid and call for more research on effective treatments.
6255 implied HN points 28 Jan 24
  1. Diagnostic errors in medicine are a serious problem, leading to harm or disability for many patients.
  2. Artificial intelligence (AI) shows promise in improving diagnostic accuracy by supporting clinicians and reducing workload.
  3. Using advanced AI models like GPT-4 can enhance diagnostic accuracy and provide valuable second opinions in medical practice.
Get a weekly roundup of the best Substack posts, by hacker news affinity:
3980 implied HN points 19 Feb 24
  1. Polygenic risk scores can provide valuable information on high genetic risk for diseases like heart disease and cancer, beyond traditional clinical risk factors.
  2. The use of polygenic risk scores is advancing thanks to efforts like the eMERGE consortium, incorporating multi-ancestry data and rigorous validation.
  3. Actionable polygenic risk scores have the potential to reduce health disparities and enhance preventive strategies in medical practice.
14434 implied HN points 08 Sep 23
  1. First human data for the new XBB.1.5 booster vaccine show good levels of neutralizing antibodies against BA.2.86 and other variants.
  2. Multiple lab studies have characterized the immune response to the BA.2.86 variant.
  3. Wastewater data and hospitalizations suggest a new wave of COVID-19 cases, highlighting the need for booster shots to provide enhanced protection against severe COVID and Long Covid.
11985 implied HN points 17 Sep 23
  1. Tolerogenic vaccines aim to suppress the immune response, offering a new approach to autoimmune diseases.
  2. Current treatments block the immune system with drugs, lacking specificity and leaving patients vulnerable to infections and side effects.
  3. Leveraging the liver's unique tolerogenic environment shows potential in inducing immune tolerance as a treatment for autoimmune conditions.
4942 implied HN points 14 Dec 23
  1. TED held its first dedicated A.I. meeting this year, featuring discussions on large language models and controversies surrounding them.
  2. The conference debated between accelerating A.I. development and approaching it with caution for safety concerns.
  3. Experts discussed Artificial General Intelligence (AGI) and its potential impact on various aspects of human activity.
7742 implied HN points 24 Sep 23
  1. The expanding GLP-1 drug family shows potential for treating obesity with new triple agonist drugs.
  2. Clinical trials with G-agonists reveal reductions in major cardiovascular events and heart failure symptoms.
  3. GLP-1 drugs have shown promise in treating early type 1 diabetes, cognitive function, alcohol use disorder, and more.
7567 implied HN points 09 Sep 23
  1. AI is on the brink of transforming our lives with the majority of interactions being with AIs, not people.
  2. The book 'THE COMING WAVE' by Mustafa Suleyman discusses the future of AI integrating life science and digital applications.
  3. The book offers a balanced perspective on AI's potential, historical context, and the challenges and opportunities it presents.
1181 implied HN points 21 Aug 23
  1. New reports show long-lasting effects of COVID-19 on health at the 2-year mark.
  2. Severe COVID-19 cases lead to worse outcomes and long-term impact compared to mild cases.
  3. Long COVID remains a significant concern, with uncertain long-term health implications like autoimmune diseases and atherosclerosis.
3 HN points 10 Feb 24
  1. Cancer cells have various tricks to evade targeted therapies like changing their driver mutation and cell identity, stealing the mitochondria from T cells, and spreading predominantly during sleep.
  2. Immune response strategies like immune checkpoint inhibitors, therapeutic cancer vaccines, antibody-drug conjugates, and oncolytic viruses are being developed to combat cancer.
  3. Combining different immunotherapy strategies and approaches like engineering T cells show promise in overcoming the challenges of treating cancer and improving patient outcomes.